AVITA Medical's RECELL Platform Wins Top Surgical Innovation Award at MedTech Breakthrough Awards

Thursday, Jun 5, 2025 11:21 am ET1min read
ASX--
MED--
RCEL--

AVITA Medical's RECELL platform, including RECELL GO, has been awarded "Best New Technology Solution – Surgical" at the 2025 MedTech Breakthrough Awards. The FDA-approved technology has treated over 30,000 patients worldwide, requiring less donor skin, reducing pain and recovery time. RECELL GO enhances procedural consistency and surgical team coordination, supporting adoption in high-volume burn centers.

Valencia, Calif., June 5, 2025 — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company, has received a significant accolade for its RECELL platform. The RECELL platform, including RECELL GO, has been recognized as the "Best New Technology Solution – Surgical" at the 2025 MedTech Breakthrough Awards. This recognition underscores the platform's innovative approach to treating thermal burn wounds and full-thickness skin defects.

The RECELL platform has been FDA-approved and has treated over 30,000 patients worldwide. The technology requires significantly less donor skin than traditional grafting, thereby reducing donor-site pain and accelerating recovery. This results in fewer procedures, improved functional and aesthetic results, and shorter hospital stays. RECELL GO enhances these clinical benefits by improving procedural consistency and surgical team coordination, making it more suitable for high-volume burn and trauma centers.

"We appreciate this recognition, which highlights RECELL’s advantages in burn and trauma care," said Jim Corbett, Chief Executive Officer of AVITA Medical. "By requiring significantly less donor skin than traditional grafting, RECELL reduces donor-site pain, accelerates healing, and improves patient outcomes. We remain committed to expanding access and advancing care for patients."

The MedTech Breakthrough Awards honor companies and products shaping healthcare's future. The 2025 program drew over 4,500 nominations globally. In addition to this recognition, Dr. Katie Bush, Senior Vice President of Scientific & Medical Affairs of AVITA Medical, was awarded the 2025 Emerald Pinnacle Healthcare Award in the Medical Device category.

References:

[1] https://ir.avitamedical.com/news-releases/news-release-details/avita-medicals-recell-platform-recognized-surgical-innovation

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet